Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer

Otolaryngology - Head and Neck Surgery

Volumn 142, Issue 3, 2010, Pages 338-343

  Kim, Jin Ho ^a   Kim, Mi Sook ^a   Yoo, Seong Yul ^a   Lim, Sang Moo ^a   Lee, Guk Haeng ^a   Yi, Ka Hee ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MEDULLARY CARCINOMA; PAPILLARY CARCINOMA; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; SALVAGE THERAPY; STEREOTACTIC BODY RADIATION THERAPY; THYROID CANCER; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; RADIOSURGERY; SALVAGE THERAPY; THYROID NEOPLASMS;

EID: 76749089512     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.12.034     Document Type: Article

References (19)

1. Kilfoy B.A., Zheng T., Holford T.R., et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20 (2009) 525-531
2. Brierley J.D., and Tsang R.W. External beam radiation therapy for thyroid cancer. Endocrinol Metab Clin North Am 37 (2008) 497-509
3. Sakorafas G.H., Sampanis D., and Safioleas M. Cervical lymph node dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties. Surg Oncol (2009 May 15) [Epub ahead of print]
4. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines taskforce. Thyroid 16 (2006) 109-142
5. Azrif M., Slevin N.J., Sykes A.J., et al. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Radiother Oncol 89 (2008) 105-113
6. Baumann P., Nyman J., Hoyer M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27 (2009) 3290-3296
7. King C.R., Brooks J.D., Gill H., et al. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 73 (2009) 1043-1048
8. Rusthoven K.E., Kavanagh B.D., Burri S.H., et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27 (2009) 1579-1584
9. Terezakis S.A., Lee K.S., Ghossein R.A., et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 73 (2009) 795-801
10. Schwartz D.L., Lobo M.J., Ang K.K., et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys 74 (2009) 1083-1091
11. Farahati J., Reiners C., Stuschke M., et al. Differentiated thyroid cancer: impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 77 (1996) 172-180
12. Keum K.C., Suh Y.G., Koom W.S., et al. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea. Int J Radiat Oncol Biol Phys 65 (2006) 474-480
13. Kim T., Yang D., Jung K., et al. Value of external irradiation for locally advanced papillary thyroid cancer. Int J Radiat Oncol Biol Phys 55 (2003) 1006-1012
14. Lee N., and Tuttle M. The role of external beam radiotherapy in the treatment of papillary thyroid cancer. Endocr Relat Cancer 13 (2006) 971-977
15. Joensuu H., and Ahonen A. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. J Nucl Med 28 (1987) 910-914
16. Feine U., Lietzenmayer R., Hanke J.P., et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37 (1996) 1468-1472
17. Robbins R.J., Wan Q., Grewal R.K., et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91 (2006) 498-505
18. Wang W., Larson S.M., Fazzari M., et al. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85 (2000) 1107-1113
19. Wang W., Larson S.M., Tuttle R.M., et al. Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. Thyroid 11 (2001) 1169-1175